Human bronchial smooth muscle cell proliferation via thromboxane A2 receptor. 2004

Yusuke Suzuki, and Koichiro Asano, and Yoshiki Shiraishi, and Tsuyoshi Oguma, and Tetsuya Shiomi, and Koichi Fukunaga, and Takeshi Nakajima, and Kyoko Niimi, and Kazuhiro Yamaguchi, and Akitoshi Ishizaka
Department of Medicine, Cardiopulmonary Division, School of Medicine, Keio University, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan.

Thromboxane A2 receptor (TP) mediates bronchial smooth muscle cell (BSMC) contraction, airway hyperresponsiveness, and airway inflammation in patients with asthma. In the present study, a pathogenic role of TP activation in airway remodeling was examined using primary cultures of human BSMC. A TP agonist, I-BOP, concentration-dependently enhanced not only bromodeoxyuridine (BrdU) uptake but also cell proliferation of BSMC. A TP-selective antagonist, AA-2414, blocked the effects of I-BOP on both BrdU uptake and cell proliferation. I-BOP-induced BrdU uptake was significantly blocked by two non-selective tyrosine kinase inhibitors, genistein and herbimycin A, or a Src family tyrosine kinase inhibitor, PP2, but not by an inhibitor of epidermal growth factor (EGF) receptor-associated tyrosine kinase, AG1478. In conclusion, TP receptor activation causes DNA synthesis and cell proliferation of human BSMC by activating tyrosine kinases including Src, but not by EGF receptor transactivation.

UI MeSH Term Description Entries
D009130 Muscle, Smooth Unstriated and unstriped muscle, one of the muscles of the internal organs, blood vessels, hair follicles, etc. Contractile elements are elongated, usually spindle-shaped cells with centrally located nuclei. Smooth muscle fibers are bound together into sheets or bundles by reticular fibers and frequently elastic nets are also abundant. (From Stedman, 25th ed) Muscle, Involuntary,Smooth Muscle,Involuntary Muscle,Involuntary Muscles,Muscles, Involuntary,Muscles, Smooth,Smooth Muscles
D010766 Phosphorylation The introduction of a phosphoryl group into a compound through the formation of an ester bond between the compound and a phosphorus moiety. Phosphorylations
D011505 Protein-Tyrosine Kinases Protein kinases that catalyze the PHOSPHORYLATION of TYROSINE residues in proteins with ATP or other nucleotides as phosphate donors. Tyrosine Protein Kinase,Tyrosine-Specific Protein Kinase,Protein-Tyrosine Kinase,Tyrosine Kinase,Tyrosine Protein Kinases,Tyrosine-Specific Protein Kinases,Tyrosylprotein Kinase,Kinase, Protein-Tyrosine,Kinase, Tyrosine,Kinase, Tyrosine Protein,Kinase, Tyrosine-Specific Protein,Kinase, Tyrosylprotein,Kinases, Protein-Tyrosine,Kinases, Tyrosine Protein,Kinases, Tyrosine-Specific Protein,Protein Kinase, Tyrosine-Specific,Protein Kinases, Tyrosine,Protein Kinases, Tyrosine-Specific,Protein Tyrosine Kinase,Protein Tyrosine Kinases,Tyrosine Specific Protein Kinase,Tyrosine Specific Protein Kinases
D001973 Bromodeoxyuridine A nucleoside that substitutes for thymidine in DNA and thus acts as an antimetabolite. It causes breaks in chromosomes and has been proposed as an antiviral and antineoplastic agent. It has been given orphan drug status for use in the treatment of primary brain tumors. BUdR,BrdU,Bromouracil Deoxyriboside,Broxuridine,5-Bromo-2'-deoxyuridine,5-Bromodeoxyuridine,NSC-38297,5 Bromo 2' deoxyuridine,5 Bromodeoxyuridine,Deoxyriboside, Bromouracil
D001980 Bronchi The larger air passages of the lungs arising from the terminal bifurcation of the TRACHEA. They include the largest two primary bronchi which branch out into secondary bronchi, and tertiary bronchi which extend into BRONCHIOLES and PULMONARY ALVEOLI. Primary Bronchi,Primary Bronchus,Secondary Bronchi,Secondary Bronchus,Tertiary Bronchi,Tertiary Bronchus,Bronchi, Primary,Bronchi, Secondary,Bronchi, Tertiary,Bronchus,Bronchus, Primary,Bronchus, Secondary,Bronchus, Tertiary
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D004815 Epidermal Growth Factor A 6-kDa polypeptide growth factor initially discovered in mouse submaxillary glands. Human epidermal growth factor was originally isolated from urine based on its ability to inhibit gastric secretion and called urogastrone. Epidermal growth factor exerts a wide variety of biological effects including the promotion of proliferation and differentiation of mesenchymal and EPITHELIAL CELLS. It is synthesized as a transmembrane protein which can be cleaved to release a soluble active form. EGF,Epidermal Growth Factor-Urogastrone,Urogastrone,Human Urinary Gastric Inhibitor,beta-Urogastrone,Growth Factor, Epidermal,Growth Factor-Urogastrone, Epidermal,beta Urogastrone
D005231 Fatty Acids, Unsaturated FATTY ACIDS in which the carbon chain contains one or more double or triple carbon-carbon bonds. Fatty Acids, Polyunsaturated,Polyunsaturated Fatty Acid,Unsaturated Fatty Acid,Polyunsaturated Fatty Acids,Acid, Polyunsaturated Fatty,Acid, Unsaturated Fatty,Acids, Polyunsaturated Fatty,Acids, Unsaturated Fatty,Fatty Acid, Polyunsaturated,Fatty Acid, Unsaturated,Unsaturated Fatty Acids
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D044244 Receptors, Thromboxane A2, Prostaglandin H2 A subclass of eicosanoid receptors that have specificity for THROMBOXANE A2 and PROSTAGLANDIN H2. Prostaglandin H2 Receptor,Receptors, Prostaglandin H2,Receptors, TXA2-PGH2,Receptors, Thromboxane A2,TXA2-PGH2 Receptors,Thromboxane A2, Prostaglandin H2 Receptors,PGH2 Receptors,Thromboxane A2 Receptor,H2 Receptors, Prostaglandin,Prostaglandin H2 Receptors,Receptor, Prostaglandin H2,Receptors, PGH2,Receptors, TXA2 PGH2,TXA2 PGH2 Receptors

Related Publications

Yusuke Suzuki, and Koichiro Asano, and Yoshiki Shiraishi, and Tsuyoshi Oguma, and Tetsuya Shiomi, and Koichi Fukunaga, and Takeshi Nakajima, and Kyoko Niimi, and Kazuhiro Yamaguchi, and Akitoshi Ishizaka
November 1995, Hypertension (Dallas, Tex. : 1979),
Yusuke Suzuki, and Koichiro Asano, and Yoshiki Shiraishi, and Tsuyoshi Oguma, and Tetsuya Shiomi, and Koichi Fukunaga, and Takeshi Nakajima, and Kyoko Niimi, and Kazuhiro Yamaguchi, and Akitoshi Ishizaka
October 1997, Circulation,
Yusuke Suzuki, and Koichiro Asano, and Yoshiki Shiraishi, and Tsuyoshi Oguma, and Tetsuya Shiomi, and Koichi Fukunaga, and Takeshi Nakajima, and Kyoko Niimi, and Kazuhiro Yamaguchi, and Akitoshi Ishizaka
January 1991, Transactions of the Association of American Physicians,
Yusuke Suzuki, and Koichiro Asano, and Yoshiki Shiraishi, and Tsuyoshi Oguma, and Tetsuya Shiomi, and Koichi Fukunaga, and Takeshi Nakajima, and Kyoko Niimi, and Kazuhiro Yamaguchi, and Akitoshi Ishizaka
January 2004, Cardiovascular radiation medicine,
Yusuke Suzuki, and Koichiro Asano, and Yoshiki Shiraishi, and Tsuyoshi Oguma, and Tetsuya Shiomi, and Koichi Fukunaga, and Takeshi Nakajima, and Kyoko Niimi, and Kazuhiro Yamaguchi, and Akitoshi Ishizaka
September 2016, The Journal of biological chemistry,
Yusuke Suzuki, and Koichiro Asano, and Yoshiki Shiraishi, and Tsuyoshi Oguma, and Tetsuya Shiomi, and Koichi Fukunaga, and Takeshi Nakajima, and Kyoko Niimi, and Kazuhiro Yamaguchi, and Akitoshi Ishizaka
January 1997, Advances in experimental medicine and biology,
Yusuke Suzuki, and Koichiro Asano, and Yoshiki Shiraishi, and Tsuyoshi Oguma, and Tetsuya Shiomi, and Koichi Fukunaga, and Takeshi Nakajima, and Kyoko Niimi, and Kazuhiro Yamaguchi, and Akitoshi Ishizaka
July 1998, Thrombosis and haemostasis,
Yusuke Suzuki, and Koichiro Asano, and Yoshiki Shiraishi, and Tsuyoshi Oguma, and Tetsuya Shiomi, and Koichi Fukunaga, and Takeshi Nakajima, and Kyoko Niimi, and Kazuhiro Yamaguchi, and Akitoshi Ishizaka
October 1992, European journal of pharmacology,
Yusuke Suzuki, and Koichiro Asano, and Yoshiki Shiraishi, and Tsuyoshi Oguma, and Tetsuya Shiomi, and Koichi Fukunaga, and Takeshi Nakajima, and Kyoko Niimi, and Kazuhiro Yamaguchi, and Akitoshi Ishizaka
December 1990, Biochemical pharmacology,
Yusuke Suzuki, and Koichiro Asano, and Yoshiki Shiraishi, and Tsuyoshi Oguma, and Tetsuya Shiomi, and Koichi Fukunaga, and Takeshi Nakajima, and Kyoko Niimi, and Kazuhiro Yamaguchi, and Akitoshi Ishizaka
November 1995, General pharmacology,
Copied contents to your clipboard!